Cargando…

A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises

BACKGROUND: To evaluate the necessity of cycloplegia for epidemiological studies of refraction in Chinese young adults (aged 17–22 years) with dark irises, and to compare the cycloplegic effects of 1% cyclopentolate and 0.5% tropicamide in them. METHODS: A total of 300 young adults (108 males and 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Ruxia, Liu, Zhuzhu, Rong, Hua, Zhao, Liqiong, Du, Bei, Jin, Na, Zhang, Hongmei, Wang, Biying, Pang, Yi, Wei, Ruihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194231/
https://www.ncbi.nlm.nih.gov/pubmed/34112149
http://dx.doi.org/10.1186/s12886-021-02001-6
_version_ 1783706377294708736
author Pei, Ruxia
Liu, Zhuzhu
Rong, Hua
Zhao, Liqiong
Du, Bei
Jin, Na
Zhang, Hongmei
Wang, Biying
Pang, Yi
Wei, Ruihua
author_facet Pei, Ruxia
Liu, Zhuzhu
Rong, Hua
Zhao, Liqiong
Du, Bei
Jin, Na
Zhang, Hongmei
Wang, Biying
Pang, Yi
Wei, Ruihua
author_sort Pei, Ruxia
collection PubMed
description BACKGROUND: To evaluate the necessity of cycloplegia for epidemiological studies of refraction in Chinese young adults (aged 17–22 years) with dark irises, and to compare the cycloplegic effects of 1% cyclopentolate and 0.5% tropicamide in them. METHODS: A total of 300 young adults (108 males and 192 females) aged 17 to 22 years (mean 19.03 ± 1.01) were recruited from Tianjin Medical University from November 2019 to January 2020. Participants were randomly divided into two groups. In the cyclopentolate group, two drops of 1% cyclopentolate eye drop were administrated (one drop every 5 min), followed by autorefraction and subjective refraction 30 to 45 min later. In the tropicamide group, four drops of 1% Mydrin P (Tropicamide 0.5%, phenylephrine HCl 0.5%) eye drop were given (one drop every 5 min), followed by autorefraction and subjective refraction 20 to 30 min later. The participants and the examiners were masked to the medication. Distance visual acuity, intraocular pressure (IOP), non-cycloplegic and cycloplegic autorefraction (Topcon KR-800, Topcon Co. Tokyo, Japan), non-cycloplegic and cycloplegic subjective refraction and ocular biometry (Lenstar LS-900) were performed. RESULTS: The values of spherical equivalent (SE) and sphere component were significantly different before and after cycloplegia in the cyclopentolate group and the tropicamide group (p < 0.05). The mean difference between noncycloplegic and cycloplegic autorefraction SE was 0.39 D (±0.66 D) in the cyclopentolate group and 0.39 D (±0.34 D) in the tropicamide group. There was no significant difference in the change of SE and sphere component after cycloplegia between the cyclopentolate group and the tropicamide group (p > 0.05). In each group, no significant difference was found between autorefraction and subjective refraction after cycloplegia (p > 0.05). We also found that more positive or less negative cycloplegic refraction was associated with the higher difference in SE in each group. CONCLUSIONS: Cycloplegic refractions were generally more positive or less negative than non-cycloplegic refractions. It is necessary to perform cycloplegia for Chinese young adults with dark irises to obtain accurate refractive errors. We suggest that cycloplegic autorefraction using tropicamide may be considered as a reliable method for epidemiological studies of refraction in Chinese young adults with dark irises. TRIAL REGISTRATION: The study was registered on September 7, 2019 (Registration number: ChiCTR1900025774).
format Online
Article
Text
id pubmed-8194231
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81942312021-06-15 A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises Pei, Ruxia Liu, Zhuzhu Rong, Hua Zhao, Liqiong Du, Bei Jin, Na Zhang, Hongmei Wang, Biying Pang, Yi Wei, Ruihua BMC Ophthalmol Research Article BACKGROUND: To evaluate the necessity of cycloplegia for epidemiological studies of refraction in Chinese young adults (aged 17–22 years) with dark irises, and to compare the cycloplegic effects of 1% cyclopentolate and 0.5% tropicamide in them. METHODS: A total of 300 young adults (108 males and 192 females) aged 17 to 22 years (mean 19.03 ± 1.01) were recruited from Tianjin Medical University from November 2019 to January 2020. Participants were randomly divided into two groups. In the cyclopentolate group, two drops of 1% cyclopentolate eye drop were administrated (one drop every 5 min), followed by autorefraction and subjective refraction 30 to 45 min later. In the tropicamide group, four drops of 1% Mydrin P (Tropicamide 0.5%, phenylephrine HCl 0.5%) eye drop were given (one drop every 5 min), followed by autorefraction and subjective refraction 20 to 30 min later. The participants and the examiners were masked to the medication. Distance visual acuity, intraocular pressure (IOP), non-cycloplegic and cycloplegic autorefraction (Topcon KR-800, Topcon Co. Tokyo, Japan), non-cycloplegic and cycloplegic subjective refraction and ocular biometry (Lenstar LS-900) were performed. RESULTS: The values of spherical equivalent (SE) and sphere component were significantly different before and after cycloplegia in the cyclopentolate group and the tropicamide group (p < 0.05). The mean difference between noncycloplegic and cycloplegic autorefraction SE was 0.39 D (±0.66 D) in the cyclopentolate group and 0.39 D (±0.34 D) in the tropicamide group. There was no significant difference in the change of SE and sphere component after cycloplegia between the cyclopentolate group and the tropicamide group (p > 0.05). In each group, no significant difference was found between autorefraction and subjective refraction after cycloplegia (p > 0.05). We also found that more positive or less negative cycloplegic refraction was associated with the higher difference in SE in each group. CONCLUSIONS: Cycloplegic refractions were generally more positive or less negative than non-cycloplegic refractions. It is necessary to perform cycloplegia for Chinese young adults with dark irises to obtain accurate refractive errors. We suggest that cycloplegic autorefraction using tropicamide may be considered as a reliable method for epidemiological studies of refraction in Chinese young adults with dark irises. TRIAL REGISTRATION: The study was registered on September 7, 2019 (Registration number: ChiCTR1900025774). BioMed Central 2021-06-10 /pmc/articles/PMC8194231/ /pubmed/34112149 http://dx.doi.org/10.1186/s12886-021-02001-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Pei, Ruxia
Liu, Zhuzhu
Rong, Hua
Zhao, Liqiong
Du, Bei
Jin, Na
Zhang, Hongmei
Wang, Biying
Pang, Yi
Wei, Ruihua
A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises
title A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises
title_full A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises
title_fullStr A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises
title_full_unstemmed A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises
title_short A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises
title_sort randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in chinese young adults with dark irises
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194231/
https://www.ncbi.nlm.nih.gov/pubmed/34112149
http://dx.doi.org/10.1186/s12886-021-02001-6
work_keys_str_mv AT peiruxia arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT liuzhuzhu arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT ronghua arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT zhaoliqiong arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT dubei arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT jinna arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT zhanghongmei arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT wangbiying arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT pangyi arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT weiruihua arandomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT peiruxia randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT liuzhuzhu randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT ronghua randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT zhaoliqiong randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT dubei randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT jinna randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT zhanghongmei randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT wangbiying randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT pangyi randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises
AT weiruihua randomizedclinicaltrialusingcyclopentolateandtropicamidetocomparecycloplegicrefractioninchineseyoungadultswithdarkirises